When was Memed founded?

Memed was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is Memed located?

Memed is headquartered in Sao Paulo, Brazil.

How many employees does Memed have?

As of Jun 30, 2026, the latest employee count at Memed is 188.

Is Memed a funded company?

Memed is a funded company, having raised a total of $97.9M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 20, 2014.

When was the latest funding round of Memed?

Memed's latest funding was a $***** Series C round on May 21, 2026, with participation from 3 investors.

Where does Memed rank among its competitors?

Memed ranks 1st amongst 65 active competitors, of which 8 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Memed, which secured $15.9M in May, 2026.

Who are the top competitors of Memed?

Memed's top competitors include Epocrates, Yuimedi and MMIT Network. Among them, Memed secured the most recent funding round in May, 2026.

Memed - 2026 Company Profile, Team, Funding & Competitors

Memed is a series C company based in Sao Paulo (Brazil), founded in 2012 by Ricardo Moraes. It operates as an Application with curated drug information used by physicians. Memed has raised $97.9M in funding from investors like DNA Capital, Temasek and DGF. The company has 65 active competitors, including 8 funded and 6 that have exited. Its top competitors include companies like Epocrates, Yuimedi and MMIT Network.

Company Details

Application with curated drug information used by physicians. The physician can quickly find the product they wanted to prescribe, remove quick doubts about dosages, customize and save used prescriptions, and know launches and market news. Aims to provide the technology capable of delivering any content relevant to day-to-day medical.

Website: memed.com.br
Social
Email ID: *****@memed.com.br

Key Metrics

Founded Year

2012

Location

Sao Paulo, Brazil

Stage

Series C

Total Funding

$97.9M in 6 rounds

Latest Funding Round

Series C, May 21, 2026, $*****

Investors

DNA Capital & 14 more

Ranked

1^st among 65 active competitors

Employee Count

188 as on Jun 30, 2026

Similar Companies

Epocrates & 84 more

View Memed's full profile

Memed has raised a total funding of $97.9M over 6 rounds. Its first funding round was on Feb 20, 2014. Its latest funding round was a Series C round on May 21, 2026 for $*****. 3 investors participated in its latest round. Memed has 15 institutional investors.

Here is the list of recent funding rounds of Memed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 21, 2026	2891605	Series C	5528886	9634858	5122481	7011012
Oct 29, 2021	3468970	Series C	4198419	8223916	2568985	6487424
Jun 16, 2021	8081379	Series C	8982392	3580727	DNA Capitals	8150068

Access funding benchmarks and valuations. Sign up today!

View details of Memed's funding rounds and investors

The founders of Memed is Ricardo Moraes.

Here are the details of Memed's key team members:

Ricardo Moraes: Co-Founder & CEO of Memed.

View details of Memed's Founder profiles and Board Members

Memed's employee count trend

Memed has 188 employees as of Jun 26. Here is Memed's employee count trend over the years:

Uncover Memed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Memed include Epocrates, Yuimedi and MMIT Network. Here is the list of Top 10 competitors of Memed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Memed 2012, Sao Paulo (Brazil), Series C	Application with curated drug information used by physicians	$97.9M	Temasek, Monashee Capital Corp & 13 others	57/100
2nd	Epocrates 1998, San Mateo (United States), Acquired	Clinical decision support tool providing continually updated medical content for clinicians	$35M	Saints Capital, Millennium Technology Value Partners ... & 8 others	54/100
3rd	Yuimedi 2020, Minato City (Japan), Seed	Provider of medical data analysis platform to enhance the healthcare system	$8.34M	DG Daiwa Ventures, Incubate Fund & 8 others	52/100
4th	MMIT Network 1994, Yardley (United States), Acquired	Provider of data, analytics, and software for pharmaceutical and healthcare sectors	$27.4M	HgCapital Trust, Welsh, Carson, Anderson & Stowe ... & 1 others	46/100
5th	Wolters Kluwer Clinical Drug Information 1978, Hudson (United States), Unfunded	Drug decision support solutions empowering healthcare professionals with trusted drug information	-	-	43/100
6th	Pharmacodia 2013, Beijing (China), Series B	Online database solutions for pharmaceutical R&D	$14.5M	Yuan Ming Capital, Shanghai Hanshi Investment Management Co ... & 2 others	40/100
7th	Posos 2018, Amiens (France), Series A	AI-based drug information and patient profiling tool for healthcare professionals	$9.54M	Caphorn, Sylvain Zimmer & 4 others	39/100
8th	First Databank 1982, Lincolnton (United States), Unfunded	Medication decision support and drug database solutions for healthcare improvement	-	-	38/100
9th	DIMS 2014, Dhaka (Bangladesh), Unfunded	A mobile based Drug Information Management System	-	-	38/100
10th	Pharma Intelligence 1998, London (United Kingdom), Acquired	Provides tools and solutions for pharmaceutical management	-	-	37/100